Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
03/2012
03/07/2012EP2424859A1 Inhibitors of pi3 kinase and / or mtor
03/07/2012EP2424858A1 Cxcr3 receptor antagonists
03/07/2012EP2424857A1 Dual-action inhibitors and methods of using same
03/07/2012EP2424856A1 Fused heterocyclic compound and use thereof
03/07/2012EP2424855A1 New photoinitiators
03/07/2012EP2424843A1 Imidazole derivatives and their use as modulators of cyclin dependent kinases
03/07/2012EP2424842A2 Dual mechanism inhibitors for the treatment of disease
03/07/2012EP2424841A1 Pyridinone antagonists of alpha-4 integrins
03/07/2012EP2424840A1 Cxcr3 receptor antagonists
03/07/2012EP2424838A1 Pesticidal arylpyrrolidines
03/07/2012EP2424533A1 Substituted isoquinoline derivatives, pharmaceutical compositions, and methods of use as -secretase inhibitors
03/07/2012EP2201002B1 5-ht7 receptor antagonists
03/07/2012EP2188253B1 Indol-2-one derivatives disubstituted in 3-position, preparation thereof and therapeutic use thereof
03/07/2012EP2111402B1 Aminopyrazole kinase inhibitors
03/07/2012EP1979331B1 Trisubstituted amine compounds as inhibitors of -cholesteryl ester transfer protein cetp
03/07/2012EP1919891B1 3,5-disubstituted pyrid-2-ones useful as inhibitors of tec family of non-receptor tyrosine kinases
03/07/2012EP1694644B1 N-aryl piperidine substituted biphenylcarboxamides as inhibitors of apolipoprotein b
03/07/2012EP1663994B1 Tetrahydroquinazoline compounds as inhibitors of voltage-gated ion channels
03/07/2012EP1542667B1 Ureido substituted benzoic acid compounds and their use for nonsense suppression and the treatment of disease
03/07/2012EP1255738B1 Gonadotropin-releasing hormone receptor antagonists and methods relating thereto
03/07/2012EP0885192B1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
03/07/2012CN1835943B 1,2,3-trisubstituted aryl and heteroaryl derivatives as modulators of metabolism and uses thereof
03/07/2012CN102369196A Azetidines as histamine h3 receptor antagonists
03/07/2012CN102369195A Autotaxin inhibitors
03/07/2012CN102369194A Novel pyrazolone-derivatives and their use as PD4 inhibitors
03/07/2012CN102369189A Fluoroquinolone carboxylic acid molecular crystals
03/07/2012CN102369188A Substituted nicotinamides as KCNQ2/3 modulators
03/07/2012CN102369187A N- (hetero)aryl, 2- (hetero)aryl-substituted acetamides for use as wnt signaling modulators
03/07/2012CN102369186A Piperidine and piperazine derivatives as autotaxin inhibitors
03/07/2012CN102367250A Lansoprazole compound and novel preparation method thereof
03/07/2012CN102367249A More stable pantoprazole compound and its pharmaceutical composition
03/07/2012CN102367248A Sparfloxacin hemisulphate, its preparation method and application
03/07/2012CN101891668B L-prolinamide derivative, preparation method and application of same
03/07/2012CN101463253B White light electroluminescent organic material based on 8-hydroxyquinoline
03/07/2012CN101432263B Substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1
03/07/2012CN101094834B Process for the manufacture of 3-hydroxy-n-alkyl-1-cycloalkyl-6-alkyl-4-oxo-1,4-dihydropyridine-2-carboxamide and its related analogues
03/06/2012US8129537 Compounds as PDE IV and TNF inhibitors
03/06/2012US8129536 Method for the purification of lansoprazole
03/06/2012US8129534 Chemical compounds
03/06/2012US8129532 Amino(oligo)thiophene dyes, preparation thereof, and optical methods of use
03/06/2012US8129528 Method for the use of [11 C] carbon monoxide in labeling synthesis of 11C-labelled amides using metal amides and photo-induced free radical carbonylation
03/06/2012US8129527 cancer and non-cancer diseases associated with vascular proliferation; mitoxantrone resistant, taxol resistant cancers
03/06/2012US8129526 Pyrimidine compound and pests controlling composition containing the same
03/06/2012US8129417 Substituted octahydrocyclopenta[C]pyrrol-4-amines as calcium channel blockers
03/06/2012US8129415 Fungicide hydroximoyl-tetrazole derivatives
03/06/2012US8129413 Crystalline forms of MC4R agonist and process for synthesis
03/06/2012US8129412 Hydantoin derivatives useful as metalloproteinase inhibitors
03/06/2012US8129411 Organic compounds
03/06/2012US8129407 Hemiasterlin derivatives and uses thereof in the treatment of cancer
03/06/2012US8129396 2-[1H-benzimidazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides and 2-[benzothiazol-2(3H)-ylidene]-2-(pyrimidin-2-yl)acetamides as kinase inhibitors
03/06/2012US8129395 4,5-disubstituted-2-aryl pyrimidines
03/06/2012US8129394 Heteroaryl-substituted imidazole compounds and uses thereof
03/06/2012US8129389 Substituted oxindole derivatives, medicaments containing the latter and use thereof
03/06/2012US8129375 Isoindoline compounds and methods of their use
03/06/2012US8129373 Carbonyl compounds
03/06/2012US8129372 Compounds having NPY Y5 receptor antagonistic activity
03/06/2012US8129358 Substituted pyrazole and triazole compounds as KSP inhibitors
03/06/2012CA2525628C New benzimidazole derivatives
03/06/2012CA2498754C Benzimidazolones and their use as cytokine inhibitors
03/06/2012CA2485532C Process for the preparation of 2-methyl piperazine derivatives
03/06/2012CA2437104C Indole compounds
03/01/2012WO2012027623A2 Cyanine dyes
03/01/2012WO2012027543A1 Solid state forms of dabigatran etexilate, dabigatran etexilate mesylate and processes for preparation thereof
03/01/2012WO2012026897A1 A process for the preparation of imatinib base
03/01/2012WO2012026766A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
03/01/2012WO2012026765A2 Novel heterocyclic compound, and composition for treating inflammatory diseases using same
03/01/2012WO2012026529A1 Novel production method for isoquinoline derivatives and salts thereof
03/01/2012WO2012026495A1 Novel hydantoin derivative and medicinal agent comprising same as active ingredient
03/01/2012WO2012025811A1 Indolylpyrimidines as modulators of gpr119
03/01/2012WO2012025473A1 Cc.chemokine receptor 4 antagonists
03/01/2012WO2012025237A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
03/01/2012WO2012025155A1 Hydroxamate-based inhibitors of deacetylases
03/01/2012WO2012004714A3 Benzene sulfonamides as inhibitors of voltage-gated sodium channels
03/01/2012WO2011117806A3 Pyridazine compounds for controlling invertebrate pests
03/01/2012US20120053350 Preparation of alkyl esters of n-protected oxo-azacycloalkylcarboxylic acids
03/01/2012US20120053345 Indazole Compounds
03/01/2012US20120053270 Polyamine derivative and polyol derivative
03/01/2012US20120053209 Anticancer compounds, preparation thereof, and therapeutic use thereof
03/01/2012US20120053193 Optically active pyrazolylaminoquinazoline, and pharmaceutical compositions and methods of use thereof
03/01/2012US20120053187 Tri-cyclic pyrazolopyridine kinase inhibitors
03/01/2012US20120053184 Salts of 3-(1h-ind0l-3-yl)-4-[2-(4-methyl-piperazin-i-yl)-quinazolin-4-yl]-pyrrole-2, 5-di one
03/01/2012US20120053179 Rho-Kinase Inhibitors
03/01/2012US20120053174 Quinazoline compounds and methods of use thereof
03/01/2012US20120053173 Heterocyclic compound
03/01/2012US20120053170 Nicotinamide derivatives, preparation thereof, and therapeutic use thereof as anticancer drugs
03/01/2012US20120053167 Triazine Derivatives as Kinase Inhibitors
03/01/2012US20120053165 Novel Phenyl Imidazoles and Phenyl Triazoles As Gamma-Secretase Modulators
03/01/2012US20120053164 Cyclic pyrimidin-4-carboxamides as ccr2 receptor antagonists for treatment of inflammation, asthma and copd
03/01/2012US20120053159 Isotopologues of lenalidomide
03/01/2012US20120053150 N-pyrazolyl carboxamides as crac channel inihibitors
03/01/2012US20120053148 Inhibitors of hepatitis c virus
03/01/2012US20120053052 3-Arylquinazolin-4-one compounds for combating invertebrate pests
03/01/2012US20120053051 5-aryl isoxazolines for controlling invertebrate pests
03/01/2012US20120052506 Cyanine dyes
03/01/2012US20120052096 Novel dioxo-imidazolidine derivatives, which inhibit the enzyme soat-1, and pharmaceutical and cosmetic compositions containing them
03/01/2012CA2805932A1 Substituted 2-amino-quinoline-3-carboxamides as kcnq2/3 modulators
02/2012
02/29/2012EP2423209A1 Bis-carbazole derivative, material for organic electroluminescent element and organic electroluminescent element using same
02/29/2012EP2423208A1 Pharmaceutically active compounds as Axl inhibitors
02/29/2012EP2423207A2 2-(cyclic amino)-pyrimidone derivatives as TPK1 inhibitors
02/29/2012EP2423199A1 Substituted imidazoles and their use as pesticides
1 ... 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 ... 1080